An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 209501
Company: UPJOHN

Medication Guide

Products on NDA 209501

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
LYRICA CR	PREGABALIN	82.5MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	Yes	No
LYRICA CR	PREGABALIN	165MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	Yes	No
LYRICA CR	PREGABALIN	330MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 209501

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/11/2017	ORIG-1	Approval	Type 5 - New Formulation or New Manufacturer	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209501s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209501Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209501Orig1s000TOC.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
04/25/2025	SUPPL-10	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209501s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/209501Orig1s010ltr.pdf
12/13/2023	SUPPL-5	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209501s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/021446Orig1s041,%20022488Orig1s018,%20209501Orig1s005Correctedltr.pdf
04/03/2020	SUPPL-3	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209501s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/209501Orig1s003ltr.pdf

Labels for NDA 209501

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
04/25/2025	SUPPL-10	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209501s010lbl.pdf
12/13/2023	SUPPL-5	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/209501s005lbl.pdf
04/03/2020	SUPPL-3	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209501s003lbl.pdf
10/11/2017	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209501s000lbl.pdf

Therapeutic Equivalents for NDA 209501

LYRICA CR

TABLET, EXTENDED RELEASE;ORAL; 82.5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LYRICA CR	PREGABALIN	82.5MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	209501	UPJOHN
PREGABALIN	PREGABALIN	82.5MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	214496	EPIC PHARMA LLC
PREGABALIN	PREGABALIN	82.5MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	213226	MSN
PREGABALIN	PREGABALIN	82.5MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	215249	RUBICON RESEARCH

TABLET, EXTENDED RELEASE;ORAL; 165MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LYRICA CR	PREGABALIN	165MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	209501	UPJOHN
PREGABALIN	PREGABALIN	165MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	214496	EPIC PHARMA LLC
PREGABALIN	PREGABALIN	165MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	213226	MSN
PREGABALIN	PREGABALIN	165MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	215249	RUBICON RESEARCH

TABLET, EXTENDED RELEASE;ORAL; 330MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
LYRICA CR	PREGABALIN	330MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	209501	UPJOHN
PREGABALIN	PREGABALIN	330MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	217857	AIPING PHARM INC
PREGABALIN	PREGABALIN	330MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	214496	EPIC PHARMA LLC
PREGABALIN	PREGABALIN	330MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	213226	MSN
PREGABALIN	PREGABALIN	330MG	TABLET, EXTENDED RELEASE;ORAL	Prescription	No	AB	215249	RUBICON RESEARCH

Top